HOME >> BIOLOGY >> NEWS
Women's math performance affected by theories on sex differences: UBC researchers

Women perform differently on math tests depending on whether they believe math-related gender differences are determined by genetic or social differences, according to University of British Columbia researchers.

In a paper to be published in the Oct. 19 issue of Science magazine, UBC investigators Ilan Dar-Nimrod and Steven Heine explore how women's math performance is affected by stereotypes that link female underachievement to either genetic or experiential causes.

Women and math is a controversial topic that led to the 2006 resignation of Lawrence Summers, the former president of Harvard who speculated that one of the potential reasons why women are represented less in math and science professions is that fewer women than men have the intrinsic ability required by such jobs.

Dar-Nimrod and Heine's research suggests that women tend to perceive gender differences in math to be innate or genetic, but when women consider such differences to be based on theories of nurture rather than nature, they can improve their performance.

"Our study doesn't explore whether innate sex differences exist," says Dar-Nimrod, a Psychology doctoral student. "Instead, we investigated how the perceived source of stereotypes can influence women's math performance."

"The findings suggest that people tend to accept genetic explanations as if they're more powerful or irrevocable, which can lead to self-fulfilling prophecies," says Assoc. Prof. Heine, who teaches in the Dept. of Psychology.

"But experiential theories may allow a woman to say this stereotype doesn't apply to me," says Heine.

Between 2003 and 2006, Dar-Nimrod and Heine conducted their research with more than 220 female participants. Their study provided participants with bogus scientific explanations for alleged sex differences in math.

Some women received a genetic account of inborn traits to explain the difference while others received an experientia
'"/>

Contact: Lorraine Chan
lorraine.chan@ubc.ca
604-822-3213
University of British Columbia
19-Oct-2006


Page: 1 2

Related biology news :

1. Brandeis and Brigham and Womens Hospital license technology for Gauchers to Amicus Therapeutics
2. Womens skin tone influences perception of beauty, health and age
3. Womens Bioethics Project unveils The Scientist & the Ethicist podcast series
4. Womens health findings presented at national conference
5. Womens bioethics project receives grant from Ford Foundation
6. 2006 SGO Annual Meeting on Womens Cancer
7. Womens health study finds vitamin E does not protect women from heart attack, stroke, or cancer
8. Womens health, tissue regeneration is focus of Illinois & Carle Hospital initiative
9. New research advances energy efficiency, safety and performance of public transit
10. Gene mutation linked to increased athletic performance in whippets
11. Individual differences in a clock gene predict decline of performance during sleep deprivation

Post Your Comments:
(Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
(Date:10/17/2014)... release is available in German . ... of sperms every day in order to reproduce? And why ... the topic of the latest issue of the research journal ... The evolutionary biologist Steven Ramm from Bielefeld University Bielefeld has ... is not unusual for a female to copulate with several ...
(Date:10/17/2014)... To date, antidotes ... doctors are often limited to supportive therapy such as induced ... of drugs involved. So what can be done if a ... professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences at ... "The task was to develop an agent that could eliminate ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Sperm wars 2Emergency aid for overdoses 2Emergency aid for overdoses 3
(Date:10/22/2014)... Oct. 22, 2014   Synthetic Biologics, Inc. ... therapies for serious infections and diseases, announced today that ... Notice of Allowance for a composition of matter patent ... difficile program, SYN-004. This is Synthetic Biologics, first ... U.S. and adds to the Company,s extensive C. ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... 20, 2014 Asterias Biotherapeutics, Inc. (NYSE ... signed a Notice of Grant Award (NGA) with ... October 1, 2014.  The NGA provides for the ... release of additional grant funds pursuant to the ... clinical development of Asterias, product, AST-OPC1. The grant ...
(Date:10/20/2014)... BOSTON , Oct. 20, 2014 ... commercialization company tackling big healthcare problems, announced today ... investment round, with participation from Invesco Perpetual, a ... be used to drive PureTech,s existing pipeline forward ... technologies. "PureTech has the scientific creativity to really ...
Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6
Cached News: